Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
- PMID: 28472961
- PMCID: PMC5418688
- DOI: 10.1186/s12933-017-0541-7
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
Erratum for
-
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.Cardiovasc Diabetol. 2017 Feb 10;16(1):23. doi: 10.1186/s12933-017-0500-3. Cardiovasc Diabetol. 2017. PMID: 28183306 Free PMC article.
References
-
- Wiemer M, Stojkovic S, Samol A, Dimitriadis Z, Ruiz-Nodar JM, Birkemeyer R, Monsegu J, Finet G, Hildick-Smith D, Tresukosol D, Novo EG, Koolen JJ, Barbato E, Danzi GB, on behalf of NOBORI 2 investigators Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up. Cardiovasc Diabetol. 2017;16:23. doi: 10.1186/s12933-017-0500-3. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
